ID   FCCM-9
AC   CVCL_F730
SY   FCCM9
DR   Wikidata; Q54833418
RX   PubMed=8095141;
RX   PubMed=8385463;
CC   Doubling time: 26.7 +- 2.6 hours (PubMed=8095141).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
RX   PubMed=8095141; DOI=10.1016/0006-2952(93)90150-u;
RA   Ramachandran C., Yuan Z.-K., Huang X.-L., Krishan A.;
RT   "Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione
RT   S-transferase pi gene expression.";
RL   Biochem. Pharmacol. 45:743-751(1993).
//
RX   PubMed=8385463; DOI=10.1016/0006-2952(93)90293-6;
RA   Ramachandran C., Samy T.S.A., Huang X.-L., Yuan Z.-K., Krishan A.;
RT   "Doxorubicin-induced DNA breaks, topoisomerase II activity and gene
RT   expression in human melanoma cells.";
RL   Biochem. Pharmacol. 45:1367-1371(1993).
//